Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Specific Focus on Clinical Cardiovascular Pharmacology
The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments to improve the pharmacological treatment of patients with cardiovascular disease.
It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.
Inhibitors of the renin–angiotensin–aldosterone system and COVID-19 in critically ill elderly patients
Author(s):Jung C, Bruno R, Wernly B, et al.
14 Jul 2020
Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series
Author(s):Della Bona R, Valbusa A, La Malfa G, et al.
07 May 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence
Author(s):Rubboli A, Valgimigli M, Capodanno D, et al.
Our mission: To reduce the burden of cardiovascular disease.
Our mission: To reduce the burden of cardiovascular disease.